Network News
[Munich, 10/03/2026] — FGK Clinical Research GmbH, a leading full-service Contract Research Organization (CRO) headquartered in Germany, is thrilled to announce the further expansion of its operative team in the Netherlands. This strategic regional expansion strengthens FGK’s European presence and commitment to high-quality clinical research services. The local Dutch team will support clinical studies in the […]
read more
Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Ladenburg, Germany, 9 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), announced on 7 March an additional amendment to its existing royalty purchase agreement with HealthCare Royalty (HCRx) and the participation of Soleus Capital Management, L.P. (Soleus Capital), a US-based life sciences investment firm, on behalf […]
read more
Still among the world’s best: Heidelberg University Hospital to remain one of the top hospitals in 2026
According to the US magazine Newsweek, Heidelberg University Hospital (UKHD) remains one of the best hospitals in the world. For its “World’s Best Hospitals 2025” ranking, Newsweek teamed up with the data platform Statista to examine 2,500 hospitals in 32 countries. The UKHD came in 12th place worldwide. In Germany, the UKHD ranks second—only Berlin’s […]
read more
2025 business results – Roche in Germany reports positive results: Roche defies the trend and invests over 700 million euros in Germany
While large parts of the German economy are stagnating, Roche is sending an encouraging signal for Germany as a business location: in fiscal year 2025, the company invested over €700 million in its German sites and increased its sales by 4.7 percent to €8.9 billion. This growth is based on targeted investments in medical progress […]
read more
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.
VERAXA’s shareholders approved the merger between VERAXA and Veraxa Biotech Holding AG and the issuance of new shares of the combined company at the Extraordinary General Meeting. Both resolutions are prerequisites for the closing of the proposed business combination among VERAXA, Veraxa Biotech Holding AG and Voyager Acquisition Corp. ZURICH, SWITZERLAND – March 2, 2026 […]
read more
Ikarovec to advance pipeline with exclusive worldwide option to VectorBuilder’s Intravitreal Capsid Technology
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease NORWICH, UK & CHICAGO, US, January 6 2026 – Ikarovec Ltd, which is developing dual-pathway gene therapies for vision-threatening retinal diseases, and VectorBuilder, a global leader in gene delivery technologies, have entered into an exclusive […]
read more
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
Cambridge, UK, 25 February 2026: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a strategic collaboration with Illumina to develop a novel automated sample preparation platform designed to streamline and standardize genomics workflows across decentralized healthcare environments. The collaboration will focus on helping labs […]
read more
€1.48 Million in Federal Funding Secured for SAM3 Research Project at Mannheim University of Applied Sciences
Mannheim University of Applied Sciences has been awarded approximately €1.48 million in federal funding for the research project SAM3 – Smart Applications for Multimodal Molecular Pattern Recognition (2026–2028). The funding is provided through the “HAW-ForschungsPraxis 2024” program of the German Federal Ministry for Research, Technology and Space. The project focuses on advancing biochemical analytics used […]
read more
Fraunhofer IGB scientist Dr. Mirko Sonntag awarded Hanse Doctoral Prize 2026
As part of his doctoral studies, Dr. Mirko Sonntag researched innovative DNA-based methods for diagnosing sepsis. For this work, he received the Hanse Doctoral Award from the Scientific Association for the Promotion of Clinically Applied Research in Intensive Care Medicine on February 12, 2026. This award honors outstanding doctoral theses in the field of intensive […]
read more
